INTRODUCTION
The α4 integrin (CD49d) or VLA4, the heterodimer of α4 and β1 integrin (CD49d/CD29) is widely expressed within and outside the hematopoietic system and exerts important functional control over many physiologic, as well as pathologic or neoplastic processes [1] [2] [3] [4] [5] [6] . Among hemopoietic cells, α4 integrin is expressed in a constitutively active stage in primitive cells and in an inactive state in several classes of mature cells 7 . It exercises a decisive influence on the migration and recruitment patterns of mature cells, especially lymphocytes, to several tissues 8 , whereas within bone marrow (BM), it plays a critical role in the interactions of hematopoietic cells with microenvironmental cells and their matrix 9 . Because of its ability to serve not only as adhesion receptor, but to execute bi-directional signaling (outside-in and inside-out 10 ), and to interact with cytokines/chemokines and other integrins expressed by hematopoietic cells or/and microenvironmental cells, α4 integrin is uniquely poised to influence interactions of hemopoietic cells with their environment.
Early studies of α4 integrin on hematopoiesis relied on the use of anti-functional antibodies, both in vitro 9 and in vivo 11 . Targeted ablation of α4 integrin caused embryonic lethality unrelated to hematopoietic effects 12 , but studies in chimeric mice showed modest effects on fetal liver hematopoiesis and no contribution to adult hematopoiesis beyond the first month of postnatal life 13, 14 .
To study the effects of α4 integrin on adult hematopoiesis, we engineered conditional knockout mice in which the α4 alleles can be disrupted upon treatment of adult animals with interferon or its inducer poly(I)-poly(C) 15 .
Adult animals with
For personal use only. on . by guest www.bloodjournal.org From conditional excision of α4 integrin maintain a quantitatively normal hematopoiesis at homeostasis, but display alterations in biodistribution of progenitor cells with sustained elevations in circulation and in the spleen. Such an effect is consequent to their compromised retention within the BM in the absence of α4 integrin an effect reminiscent of the mobilization seen in vivo with anti-α4 antibodies 11 . A counterpart of this effect is a partial impairment in BM homing and in short-term engraftment 15 . In order to test the ability of α4 deficient cells for long-term, durable engraftment in irradiated recipients and the self-renewal properties of α4 Δ/Δ HSCs, in the present study we carried out a series of transplantation experiments with or without competitor cells. Our results suggest that absence of α4 integrin in hematopoietic cells greatly compromises their competitive ability for hemopoietic reconstitution and their self-renewal capacity in serial transplantations.
MATERIALS AND METHODS

Mice
Mx.cre+ α4 f/f and Mx.cre+ α4 Δ/Δ mice were generated in our laboratory as described previously 15 . Three injections of poly(I)-poly(C) every other day were used for ablation of adult animals, whereas in neonates, two injections were used during the first week of postnatal life. Alpha4 ablation was tested two weeks later. Ablated animals are referred to as α4 Δ/Δ and the animals with >5% α4+ cells in their peripheral blood were not included in experiments. Mice were bred and maintained in the specific pathogen free facility at the University of Washington in accordance with the Institutional Animal Care Use Committee guidelines.
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Cells from mouse tissues (bone marrow, peripheral blood or spleen) were stained using the following directly conjugated antibodies from BDBiosciences (San Diego, CA): B220 (RA3-682), CD3 (17A2), CD4 (RM4-5), CD8 (53-6.7), CD45 (30F-11), TER119, Mac-1 (M1/70), Gr-1 (RB6-8C5), CD117 (c-kit, 2B8), Sca-1 (D7), CD29 (β1, Ha2/5), anti-CD48 (HM48-1), CD49e (α5, 5H10-27 [MFR5]), anti-CD150 and anti-α4β7 (DATK32), directly conjugated CD150 (SLAM, IPO-3) purchased from eBioscience (San Diego, CA) and directly conjugated CD49d (anti-α4, PS/2) antibody was purchased from Southern Biotechnology Associates, Birmingham, AL. The cocktail of antibodies used for staining of Lineage-committed cells included: CD3 (17A2), Mac-1, TER119, Gr-1, B220. A FACSCalibur (BD Biosciences) and the CELLQuest software were used for cell analysis.
Proliferation assessment.
Assessment of proliferative status of BM cells of α4 Δ/Δ and of controls (α4 f/f ) was done using a single injection of BrDU (250 mg/kg body weight) and analyzing the cells 3 hours later, as described 16 . BrDU staining was carried out according to the manufacturer's instructions, and was combined with anti-CD45-PE or anti-kit-APC.
Competitive repopulation.
Pooled BM cells from α4 Δ/Δ mice (=Test cells) were mixed in different proportions (250,000-750,000) with α4 f/f /cre− cells (250,000) (=Competitor cells) and transplanted by i.v. injection (0.5-1.0 × 10 6 ) into lethally irradiated (1200 cGy at a dose rate of >100
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cre+ BM cells before ablation were competed (1:1) with α4 +/+ Mx.cre+ cells.
Recipients of the latter pool of BM were ablated [by poly(I)-poly(C)] 4 weeks post transplantation. BM and PB cells of all recipients were evaluated at several points post transplantation by FACS, CFU-C cultures in the presence or absence of G418, and by genomic analysis (PCR). At chosen times post transplantation, selected 1° recipients served as donors for 2° transplants which were similarly analyzed 3-6 months later.
Transplantation of α4-deficient BM or PB.
Bone marrow cells (1-5 × 10 6 cells/recipient) from α4 ablated mice were infused into lethally irradiated recipients (1150 cGy whole body irradiation with a 137 Cs source).
Both splenectomized and non-splenectomized animals were used as recipients.
Recipients were analyzed at 2, 10, 16, and 56 weeks later and serial transplantations (2° and 3°) were carried out from selected 1° and 2° recipient (α4 +/+ , or α4
Evaluation of hematopoietic reconstitution was carried out by FACS for different cell lineages, by hematopoietic cell quantitation in BM, PB and spleen, and through CFU-C assays with our without G418. Presence of "floxed" (f), "deleted" (Δ) or "WT" alleles were used in genomic analysis to assess donor cell contribution. Peripheral blood was also used for transplantation (0.3 mL from α4 Δ/Δ or α4 +/+ animals).Recipients were analyzed 4 months later, using the approaches described above. All procedures were approved by the University of Washington Institutional Animal Care and Use Committee (IACUC).
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Clonogenic Progenitor Assays.
Colony-Forming-Unit-in Culture (CFU-C) assays were performed using a methylcellulose mixture (Methocult™ GF, Stem Cell Technologies, Vancouver, BC), as described previously 15 . BM or PB cells were inoculated for culture, and colonies were identified morphologically in culture plates as erythroid (BFUe), or granulocyte/macrophage (CFU-GM) or CFU-Mixed. Whenever appropriate, G418 was added to cultures to test for the presence of the neo-allele in α4-unexcised cells (α4
providing complementary evidence to that from genomic PCR analysis.
Genomic PCR. Genomic DNA was isolated using a Gentra Kit (Gentra Systems, Minneapolis, MN). The following primer combinations were used for PCR: α4 gene- Statistical analyses were performed by using a Student t-test. . It is of interest that all kit+ cells were CD48+ in both sets of animals.
For personal use only. on . by guest www.bloodjournal.org From BM of all recipients of 1:1 ratio were G418 resistant (i.e., α4 f/f derived), whereas in PB were 83.6±18.4%, and in the recipients of 3:1 donor pool, they were 95.5±2.4% and 80.84±6.0%, respectively. Moreover, DNA analysis of BM cells from all these recipients (Fig. 3C ) confirmed the derivation of the great majority of multilineage hematopoiesis by α4 f/f competitor cells (Fig. 4) . α4Δ/Δrecipients, despite their higher cellularity in BM, the frequency of CFU-C was lower than +/+ controls, but not statistically significant. **P<.02
In the long term donor reconstitution experiments, by 10-16 weeks bone marrow cellularity and progenitor content recovered to levels seen in concurrent controls (Table   1 ). This recovery had the hallmarks of α4 Δ/Δ hematopoiesis before transplantation:
increase in progenitors in circulation and in spleen. However, detailed evaluation of 3 mice at 10 weeks showed that kit+/α4+ were 46.4% in one of them, and in their spleens
For personal use only. on April 13, 2017. by guest www.bloodjournal.org From all three animals showed a significant increase in total α4+ cells (24.5%, 11.2% and 9.6%) and among kit+ cells (31.3%, 37.6% and 55.7%). Observations in the cohort of splenectomized recipients given the same number of α4 Δ/Δ cells and evaluated at 10 weeks post-transplantation also showed an increase in α4+ cells (7 recipients, 16.3±3.5%) and no increase in circulating progenitors compared to non-splenectomized recipients (118±36.9/mL vs. 564±46.4, Table 1 ).
In contrast to data at 10-16 weeks ( To assess the self-renewal capacity of α4 Δ/Δ HSCs, we carried out 2° transplantation experiments, both at 10 weeks, i.e. at the recovery phase, and at 56 weeks post-transplantation. As indicated above, one of the 3 mice evaluated at 10 weeks had ~50% α 4 + cells in circulation, whereas the other two had mostly α 4 Δ/Δ cells in circulation (Table 2 and Fig. 5 ). The latter two mice served as donors for five 2° recipients (1 × 10 6 /recipient) and the one pseudo-chimeric mouse served as a donor for another five recipients. α4 +/+ cells from control 1° recipients were also transplanted in five 2° hosts. All recipients were evaluated about 4 months later. The data are shown in Table 1 for additional data.). 2° transplantations (see also Table 2 ) were done at 10 or 56 weeks post 1° transplantation and were tested 16 and 26 weeks post 2° transplantation (white mice: <10% α4+ cells; grey mice: >10% α4+ cells; black mice: dead). Note the tendency in all 2° transplant recipients for reconstitution by surviving α4+ cells from hosts (grey mice). In 3° transplants, there was only 30% survival (B) and the 6 surviving mice (#1-6 in Fig. 5C ) were reconstituted mostly (mice #1-4) by host cells that were neo-negative (=WT). Two mice (#5, 6) showing neo+ in (C) were not reconstituted by unablated α4 f/f cells, but by host cells, since these recipients were f/f/cre(-)/neo+ mice.
In addition to BM, PB cells from α4 Δ/Δ mice were transplanted into lethally irradiated recipients to test for LTRCs in the circulation of these mice. For this purpose, blood from α4 +/+ or α4 Δ/Δ mice was given to 10 irradiated recipients from each group (0.3 mL/recipient). By day 30 all control recipients died, however, 3 of the recipients of α4 Δ/Δ survived beyond 90 days (Fig. 6 ). These recipients were sacrificed six months later for evaluation and showed greatly diminished hematopoiesis (i.e., decreased CFU-C content in BM, no increase of progenitors in circulation or in spleen, data not shown) similar to features seen long term from BM α4 Δ/Δ cells. These results unequivocally suggest that the number of long term repopulating cells is increased in circulation of α4 Δ/Δ animals compared to control animals, since despite their putative homing defect, they can establish long term hematopoiesis in 1° recipients. For
DISCUSSION
Our previous studies in mice with α4 integrin gene ablation during adult life have shown no quantitative abnormalities in hematopoiesis during homeostasis for more than a year 15 . However, there were aberrations in biodistribution of hematopoietic progenitors, which remained elevated in peripheral blood and were sequestered in the spleen. Furthermore, α4 Δ/Δ BM cells had a partially impaired homing when given to irradiated recipients, confirming many prior studies using anti-functional α4 antibodies 18 .
In addition, there was a significant deficiency in short term engraftment during the first few weeks post-transplantation, suggesting impairment in expansion of hematopoiesis under stress, in agreement with independent studies of post 5FU-recovery 15 and engraftment studies with anti-α4 treated cells delivered intra-femorally 19 . As the role of α4 integrins in the establishment and maintenance of long-term hematopoiesis was not clear from prior data, the present studies were undertaken.
Alpha4 deficient donor cells display a competitive disadvantage in repopulation experiments.
All experiments in which α4 Δ/Δ cells were transplanted together with α4 influencing HSC retention at the niche, especially by osteoblasts, a critical structural "niche" component [45] [46] [47] . Such a close interaction between stem cells and osteoblasts towards hypoxic areas of bone marrow (like the endosteal surface) maintains stem cell
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It is of interest that the adhesion through the Tie2 expressed by stem cells and of Ang-1 expressed by osteoblasts was inhibited by β1 and α4 integrins 23, 45 . Thus, the latter can presumably influence stem cell contact at the "niche" downstream of the Tie2/Ang-1 molecular pathway. Furthermore, osteoblasts express an abundance of osteopontin 48 and the latter is an important ligand for α4 integrins 49, 50 . Additional adhesive pathways controlled by Myc expression were also postulated to affect HSC/niche interactions 44 . Loss or overexpression of Myc in HSC led to increase or decrease respectively of adhesion molecules involved in HSC -niche interaction (44).
However, in these studies mainly β2 integrins were involved and no preferential maintenance of Myc −/− cells at endorsteal sites was documented. Whatever the nature of adhesion molecules involved it is presently unclear whether they function only as adhesion receptors or participate in signaling cascades required to retain cells at the niche. Moreover, it is presently unsettled whether osteoblasts lining the endosteal areas of bone marrow comprise the only unique stem cell "niches" important for preservation of stem cell function. Such a concept, for example, will not explain the survival and function of HSCs in extramedullary sites. Indeed, despite the recent resurgence of evidence favoring the endosteal niche definition, new evidence suggests that sinusoidal endothelial cells create a "niche" for HSCs that sustains a substantial fraction of the HSC pool 51 . This concept is further bolstered by the fact that there are no frequency differences in HSCs among bones with different ratios of endosteal to central bone marrow, both when examined by modern approaches 52 or by decades-old approache 53 . Furthermore, it is unclear whether geographic differences in the distribution of stem cells reported in normal, non-conditioned bone marrow by old 54 or by newer studies 55 are abolished or disturbed in response to injury (i.e. post lethal irradiation).
Whatever the anatomic location of stem cell "niche", perivascular or endosteal, a close contact likely protects the survival of stem cells and assures their quiescence. It is theoretically possible that an integrin, i.e., α4, may be one of the participating molecules securing the close contact of stem cells with cells at the niche, but further studies are needed to approach this issue.
